Zolpidem use and the risk of arrhythmia: A nationwide population-based cohort study in Taiwan
Zolpidem use is independently associated with an increased risk of incident arrhythmia, particularly tachyarrhythmias such as paroxysmal tachycardia and atrial flutter. Clinicians should incorporate cardiac risk assessment into their prescribing decisions and consider periodic monitoring for high-risk patients. Study limitations include the observational design and the unavailability of granular dosage data.
Authors
- Chun‐An Cheng (ORCID: https://orcid.org/0000-0002-0380-7286)
- Jiaying Shen
- Yuan Hung (ORCID: https://orcid.org/0000-0002-2199-8338)
- Hong-Jhe Chen
- C. K. Chen
- Hsun Ou (ORCID: https://orcid.org/0000-0003-4910-4022)
- W. U.Chien Chien
- Brendon Stubbs
- Tien-Yu Chen
Institutions
- University of Vienna (AT)
- National Yang Ming Chiao Tung University (TW)
- King's College London (GB)
- Taipei Medical University Hospital (TW)
- Austrian Institute for Sports Medicine (AT)
- Keelung Chang Gung Memorial Hospital (TW)
- Taiwan Nurses Association (TW)
- Pingtung Hospital (TW)
- National Defense Medical Center (TW)
- National Chengchi University (TW)
Publication Details
- Journal
- Journal of the Chinese Medical Association
- Published
- 2026-03-03
- DOI
- https://doi.org/10.1097/jcma.0000000000001360
- Primary Topic
- Cardiovascular Syncope and Autonomic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00